Concepedia

Elaine Shum

ES

Statistics

Publications

27

Citations

1.1K

H-Index

17

Active since

2006

Affiliations

NYU Langone Health(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

New York University

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Elaine Shum is an author at NYU Langone Health specializing in oncology, medicine, and molecular oncology.

Publications per year

2006–2025

27

Publications

27

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Jamie E. Chaft, Filiz Öezkan, Mark G. Kris et al. · Nature Medicine · 2022 · 237 citations · Full text

Medicine, Oncology, Pharmacology +17

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Matthew D. Hellmann, Pasi A. Jänne, Mateusz Opyrchal et al. · Clinical Cancer Research · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation

Jessica Ho, Bobo Wing-Yee Mok, Laura Campisi et al. · Cell · 2021 · 122 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

Jacob Sands, Myung‐Ju Ahn, Aaron Lisberg et al. · Journal of Clinical Oncology · 2025 · 98 citations · Full text

Medicine, Oncology, Pharmacology +16

Selective Personalized RadioImmunotherapy for Locally Advanced Non–Small-Cell Lung Cancer Trial (SPRINT)

Nitin Ohri, Shruti Jolly, Benjamin T. Cooper et al. · Journal of Clinical Oncology · 2023 · 60 citations

Medicine, Oncology, Radiation Oncology +17

1–5 of 27